11-ketoprogesterone has been researched along with Prostatic Neoplasms in 2 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, EE; Swart, AC; van Rooyen, D; Yadav, R | 1 |
| Bloem, LM; du Toit, T; Gent, R; Swart, AC | 1 |
2 other study(ies) available for 11-ketoprogesterone and Prostatic Neoplasms
| Article | Year |
|---|---|
CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Cell Line, Tumor; Gonadal Steroid Hormones; HEK293 Cells; Humans; Hydroxyprogesterones; Male; Progesterone; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Testosterone | 2020 |
The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Androstenes; Biosynthetic Pathways; Cell Line, Tumor; HEK293 Cells; Humans; Male; Progesterone; Prostatic Neoplasms; Protein Isoforms; Substrate Specificity; Testosterone | 2019 |